Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease

Neuropharmacology

Volumn 76, Issue PART A, 2014, Pages 51-56

  Canas, Paula M ^a   Simões, Ana Patrícia ^a   Rodrigues, Ricardo J ^a   Cunha, Rodrigo A ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

amyloid; Alzheimer's disease; Cholinergic; Glutamatergic; Nerve terminal; Synaptosomes

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; AMYLOID BETA PROTEIN[1-42]; VESICULAR ACETYLCHOLINE TRANSPORTER; VESICULAR GLUTAMATE TRANSPORTER 1;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MALE; MEMORY DISORDER; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; WESTERN BLOTTING;

ALZHEIMER'S DISEASE; CHOLINERGIC; GLUTAMATERGIC; NERVE TERMINAL; SYNAPTOSOMES; Β-AMYLOID;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; MICE; MICROINJECTIONS; PEPTIDE FRAGMENTS; PILOT PROJECTS; PRESYNAPTIC TERMINALS; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; VESICULAR INHIBITORY AMINO ACID TRANSPORT PROTEINS;

EID: 84886592954     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.08.026     Document Type: Article

References (84)

1. S. Agarwal, R.K. Tannenberg, and P.R. Dodd Reduced expression of the inhibitory synapse scaffolding protein gephyrin in Alzheimer's disease J. Alzheimers Dis. 14 2008 313 321 (Pubitemid 352040046)
2. P. Agostinho, R.A. Cunha, and C. Oliveira Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease Curr. Pharm. Des. 16 2010 2766 2778
3. I.A. Alhaider, A.M. Aleisa, T.T. Tran, and K.A. Alkadhi Caffeine prevents sleep loss-induced deficits in long-term potentiation and related signaling molecules in the dentate gyrus Eur. J. Neurosci. 31 2010 1368 1376
4. C.G. Almeida, D. Tampellini, R.H. Takahashi, P. Greengard, M.T. Lin, E.M. Snyder, and G.K. Gouras Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses Neurobiol. Dis. 20 2005 187 198 (Pubitemid 41476246)
5. A. Auffret, V. Gautheron, M. Repici, R. Kraftsik, H.T. Mount, J. Mariani, and C. Rovira Age-dependent impairment of spine morphology and synaptic plasticity in hippocampal CA1 neurons of a presenilin 1 transgenic mouse model of Alzheimer's disease J. Neurosci. 29 2009 10144 10152
6. D.S. Auld, T.J. Kornecook, S. Bastianetto, and R. Quirion Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies Prog. Neurobiol. 68 2002 209 245 (Pubitemid 35346805)
7. D. Baglietto-Vargas, I. Moreno-Gonzalez, R. Sanchez-Varo, S. Jimenez, L. Trujillo-Estrada, E. Sanchez-Mejias, M. Torres, M. Romero-Acebal, D. Ruano, M. Vizuete, J. Vitorica, and A. Gutierrez Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus J. Alzheimers Dis. 21 2010 119 132
8. R.T. Bartus, R.L. Dean 3rd, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
9. 2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation Mol. Psychiatry 18 2013 320 331
10. K.F. Bell, and A.C. Cuello Altered synaptic function in Alzheimer's disease Eur. J. Pharmacol. 545 2006 11 21 (Pubitemid 44219049)
11. K.F. Bell, G.J. de Kort, S. Steggerda, R. Shigemoto, A. Ribeiro-da-Silva, and A.C. Cuello Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology Neurosci. Lett. 353 2003 143 147 (Pubitemid 37510201)
12. K.F. Bell, A. Ducatenzeiler, A. Ribeiro-da-Silva, K. Duff, D.A. Bennett, and A.C. Cuello The amyloid pathology progresses in a neurotransmitter-specific manner Neurobiol. Aging 27 2006 1644 1657 (Pubitemid 44344842)
13. P.M. Canas, L.O. Porciúncula, G.M. Cunha, C.G. Silva, N.J. Machado, J.M. Oliveira, C.R. Oliveira, and R.A. Cunha Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway J. Neurosci. 29 2009 14741 14751
14. J.R. Cirrito, J.E. Kang, J. Lee, F.R. Stewart, D.K. Verges, L.M. Silverio, G. Bu, S. Mennerick, and D.M. Holtzman Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo Neuron 58 2008 42 51 (Pubitemid 351467029)
15. 2A receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life J. Neurochem. 112 2010 453 462
16. S.E. Counts, and E.J. Mufson The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease J. Neuropathol. Exp. Neurol. 64 2005 263 272 (Pubitemid 40489553)
17. 2A receptors upon sub-chronic restraint stress Neuroscience 141 2006 1775 1781 (Pubitemid 44233132)
18. C. Cunningham, R. Deacon, H. Wells, D. Boche, S. Waters, C.P. Diniz, H. Scott, J.N. Rawlins, and V.H. Perry Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease Eur. J. Neurosci. 17 2003 2147 2155 (Pubitemid 36713975)
19. K.L. Davis, R.C. Mohs, D. Marin, D.P. Purohit, D.P. Perl, M. Lantz, G. Austin, and V. Haroutunian Cholinergic markers in elderly patients with early signs of Alzheimer disease JAMA 281 1999 1401 1406 (Pubitemid 29190218)
20. M. D'Amelio, V. Cavallucci, S. Middei, C. Marchetti, S. Pacioni, A. Ferri, A. Diamantini, D. De Zio, P. Carrara, L. Battistini, S. Moreno, A. Bacci, M. Ammassari-Teule, H. Marie, and F. Cecconi Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease Nat. Neurosci. 14 2011 69 76
21. S.M. de la Monte Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease Curr. Alzheimer Res. 9 2012 35 66
22. J.M. Duarte, P.M. Agostinho, R.A. Carvalho, and R.A. Cunha Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice PLoS One 7 2012 e21899
23. P.R. Dunkley, P.E. Jarvie, and P.J. Robinson A rapid Percoll gradient procedure for preparation of synaptosomes Nat. Protoc. 3 2008 1718 1728
24. A.M. Fagan, C.M. Roe, C. Xiong, M.A. Mintun, J.C. Morris, and D.M. Holtzman Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults Arch. Neurol. 64 2007 343 349 (Pubitemid 46425688)
25. J.T. Gau, M.L. Steinhilb, T.C. Kao, C.J. D'Amato, J.R. Gaut, K.A. Frey, and R.S. Turner Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice Am. J. Pathol. 160 2002 731 738 (Pubitemid 34160351)
26. T. Harkany, I. Abrahám, W. Timmerman, G. Laskay, B. Tóth, M. Sasvári, C. Kónya, J.B. Sebens, J. Korf, C. Nyakas, M. Zarándi, K. Soós, B. Penke, and P.G. Luiten Beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis Eur. J. Neurosci. 12 2000 2735 2745
27. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
28. J. Hardy, R. Cowburn, A. Barton, G. Reynolds, E. Lofdahl, A.M. O'Carroll, P. Wester, and B. Winblad Region-specific loss of glutamate innervation in Alzheimer's disease Neurosci. Lett. 73 1987 77 80 (Pubitemid 17207727)
29. J. Hardy, R. Cowburn, A. Barton, G. Reynolds, P. Dodd, P. Wester, A.M. O'Carroll, E. Lofdahl, and B. Winblad A disorder of cortical GABAergic innervation in Alzheimer's disease Neurosci. Lett. 73 1987 192 196 (Pubitemid 17223705)
30. L. Hu, T.P. Wong, S.L. Côté, K.F. Bell, and A.C. Cuello The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in Alzheimer's disease-like transgenic mice Neuroscience 121 2003 421 432 (Pubitemid 37176929)
31. A.Y. Hsia, E. Masliah, L. McConlogue, G.Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R.C. Malenka, R.A. Nicoll, and L. Mucke Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc. Natl. Acad. Sci. U. S. A. 96 1999 3228 3233 (Pubitemid 29148873)
32. H. Hsieh, J. Boehm, C. Sato, T. Iwatsubo, T. Tomita, S. Sisodia, and R. Malinow AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss Neuron 52 2006 831 843 (Pubitemid 44828454)
33. M.D. Ikonomovic, E.J. Mufson, J. Wuu, E.J. Cochran, D.A. Bennett, and S.T. DeKosky Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology J. Alzheimers Dis. 5 2003 39 48 (Pubitemid 36422850)
34. J.S. Jacobsen, C.C. Wu, J.M. Redwine, T.A. Comery, R. Arias, M. Bowlby, R. Martone, J.H. Morrison, M.N. Pangalos, P.H. Reinhart, and F.E. Bloom Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 103 2006 5161 5166
35. S. Kar, D. Seto, P. Gaudreau, and R. Quirion β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices J. Neurosci. 16 1996 1034 1040 (Pubitemid 26140859)
36. A. Kashani, E. Lepicard, O. Poirel, C. Videau, J.P. David, C. Fallet-Bianco, A. Simon, A. Delacourte, B. Giros, J. Epelbaum, C. Betancur, and S. El Mestikawy Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease Neurobiol. Aging 29 2008 1619 1630
37. S.L. Kirvell, M. Esiri, and P.T. Francis Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease J. Neurochem. 98 2006 939 950 (Pubitemid 44051293)
38. S.L. Kirvell, M.S. Elliott, R.N. Kalaria, T. Hortobagyi, C.G. Ballard, and P.T. Francis Vesicular glutamate transporter and cognition in stroke: a case-control autopsy study Neurology 75 2010 1803 1809
39. A. Köfalvi, R.J. Rodrigues, C. Ledent, K. Mackie, E.S. Vizi, R.A. Cunha, and B. Sperlágh Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis J. Neurosci. 25 2005 2874 2884 (Pubitemid 40389245)
40. S. Krantic, N. Isorce, N. Mechawar, M.A. Davoli, E. Vignault, M. Albuquerque, J.G. Chabot, E. Moyse, J.P. Chauvin, I. Aubert, J. McLaurin, and R. Quirion Hippocampal GABAergic neurons are susceptible to amyloid-beta toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model J. Alzheimers Dis. 29 2012 293 308
41. P.N. Lacor, M.C. Buniel, L. Chang, S.J. Fernandez, Y. Gong, K.L. Viola, M.P. Lambert, P.T. Velasco, E.H. Bigio, C.E. Finch, G.A. Krafft, and W.L. Klein Synaptic targeting by Alzheimer's-related amyloid beta oligomers J. Neurosci. 24 2004 10191 10200 (Pubitemid 39492046)
42. P.A. Lawlor, and D. Young Aβ infusion and related models of Alzheimer dementia P.P. De Deyn, D. Van Dam, Animal Models of Dementia 2010 Springer New York 347 370
43. G. León-Espinosa, J. DeFelipe, and A. Muñoz Effects of amyloid-β plaque proximity on the axon initial segment of pyramidal cells J. Alzheimers Dis. 29 2012 841 852
44. L. Liu, I.J. Orozco, E. Planel, Y. Wen, A. Bretteville, P. Krishnamurthy, L. Wang, M. Herman, H. Figueroa, W.H. Yu, O. Arancio, and K. Duff A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment Neurobiol. Dis. 31 2008 46 57
45. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel, and J. Rogers Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862 (Pubitemid 29426831)
46. E. Masliah, R.D. Terry, R.M. DeTeresa, and L.A. Hansen Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease Neurosci. Lett. 103 1989 234 239 (Pubitemid 19201259)
47. E. Masliah, M. Mallory, L. Hansen, R. DeTeresa, and R.D. Terry Quantitative synaptic alterations in the human neocortex during normal aging Neurology 43 1993 192 197 (Pubitemid 23035380)
48. E. Masliah, M. Alford, M. Mallory, E. Rockenstein, D. Moechars, and F. Van Leuven Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice Exp. Neurol. 163 2000 381 387 (Pubitemid 30399086)
49. 2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake J. Alzheimers Dis. 31 2012 555 567
50. M.P. Mattson, J. Partin, and J.G. Begley Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites Brain Res. 807 1998 167 176 (Pubitemid 29005249)
51. R. Minkeviciene, J. Ihalainen, T. Malm, O. Matilainen, V. Keksa-Goldsteine, G. Goldsteins, H. Iivonen, N. Leguit, J. Glennon, J. Koistinaho, P. Banerjee, and H. Tanila Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice J. Neurochem. 105 2008 584 594 (Pubitemid 351562711)
52. L. Mucke, E. Masliah, G.Q. Yu, M. Mallory, E.M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J. Neurosci. 20 2000 4050 4058 (Pubitemid 30365675)
53. J. Näslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard, and J.D. Buxbaum Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline JAMA 283 2000 1571 1577 (Pubitemid 30161512)
54. N. Nunes-Tavares, L.E. Santos, B. Stutz, J. Brito-Moreira, W.L. Klein, S.T. Ferreira, and F.G. de Mello Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-β peptide oligomers J. Biol. Chem. 287 2012 19377 19385
55. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421 (Pubitemid 36937044)
56. J.J. Palop, and L. Mucke Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks Nat. Neurosci. 13 2010 812 818
57. S.E. Perez, S. Dar, M.D. Ikonomovic, S.T. DeKosky, and E.J. Mufson Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse Neurobiol. Dis. 28 2007 3 15 (Pubitemid 47429971)
58. P.E. Potter, P.K. Rauschkolb, Y. Pandya, L.I. Sue, M.N. Sabbagh, D.G. Walker, and T.G. Beach Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease Acta Neuropathol. 122 2011 49 60
59. D.T. Proctor, E.J. Coulson, and P.R. Dodd Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology J. Alzheimers Dis. 21 2010 795 811
60. J.C. Richardson, C.E. Kendal, R. Anderson, F. Priest, E. Gower, P. Soden, R. Gray, S. Topps, D.R. Howlett, D. Lavender, N.J. Clarke, J.C. Barnes, R. Haworth, M.G. Stewart, and H.T. Rupniak Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease Neuroscience 122 2003 213 228 (Pubitemid 37329960)
61. 2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum J. Neurochem. 92 2005 433 441 (Pubitemid 40189447)
62. R.J. Rodrigues, P.M. Canas, L.V. Lopes, C.R. Oliveira, and R.A. Cunha Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats Neurobiol. Aging 29 2008 1597 1601
63. B.P. Rutten, N.M. Van der Kolk, S. Schafer, M.A. van Zandvoort, T.A. Bayer, H.W. Steinbusch, and C. Schmitz Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L transgenic mice Am. J. Pathol. 167 2005 161 173 (Pubitemid 40884779)
64. P.E. Sanchez, L. Zhu, L. Verret, K.A. Vossel, A.G. Orr, J.R. Cirrito, N. Devidze, K. Ho, G.Q. Yu, J.J. Palop, and L. Mucke Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model Proc. Natl. Acad. Sci. U. S. A. 109 2012 E2895 E2903
65. A. Schallier Region- and age-specific changes in glutamate transport in the AbetaPP23 mouse model for Alzheimer's disease J. Alzheimers Dis. 24 2011 287 300
66. S.W. Scheff, S.T. DeKosky, and D.A. Price Quantitative assessment of cortical synaptic density in Alzheimer's disease Neurobiol. Aging 11 1990 29 37 (Pubitemid 20097857)
67. S.W. Scheff, D.A. Price, F.A. Schmitt, and E.J. Mufson Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment Neurobiol. Aging 27 2006 1372 1384 (Pubitemid 44279897)
68. D.J. Selkoe Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior Behav. Brain Res. 192 2008 106 113
69. G.M. Shankar, B.L. Bloodgood, M. Townsend, D.M. Walsh, D.J. Selkoe, and B.L. Sabatini Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway J. Neurosci. 27 2007 2866 2875 (Pubitemid 46438992)
70. N.R. Sims, D.M. Bowen, S.J. Allen, C.C. Smith, D. Neary, D.J. Thomas, and A.N. Davison Presynaptic cholinergic dysfunction in patients with dementia J. Neurochem. 40 1983 503 509 (Pubitemid 13195690)
71. S. Sokolow, S.H. Luu, K. Nandy, C.A. Miller, H.V. Vinters, W.W. Poon, and K.H. Gylys Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex Neurobiol. Dis. 45 2012 381 387
72. C.I. Sze, H. Bi, B.K. Kleinschmidt-DeMasters, C.M. Filley, and L.J. Martin Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains J. Neurol. Sci. 175 2000 81 90 (Pubitemid 30265473)
73. S. Takamori, J.S. Rhee, C. Rosenmund, and R. Jahn Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons Nature 407 2000 189 194
74. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
75. S.M. Togga, E. Masliah, and L. Mucke Prevention of HIV-1 gp120- induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine Brain Res. 706 1996 303 307 (Pubitemid 26046728)
76. F. Trinchese, S. Liu, F. Battaglia, S. Walter, P.M. Mathews, and O. Arancio Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice Ann. Neurol. 55 2004 801 814 (Pubitemid 38702575)
77. D. Van Dam, and P.P. De Deyn Animal models in the drug discovery pipeline for Alzheimer's disease Br. J. Pharmacol. 164 2011 1285 1300
78. D.V. Venkitaramani, J. Chin, W.J. Netzer, G.K. Gouras, S. Lesne, R. Malinow, and P.J. Lombroso β-amyloid modulation of synaptic transmission and plasticity J. Neurosci. 27 2007 11832 11837 (Pubitemid 350072092)
79. L. Verret, E.O. Mann, G.B. Hang, A.M. Barth, I. Cobos, K. Ho, N. Devidze, E. Masliah, A.C. Kreitzer, I. Mody, L. Mucke, and J.J. Palop Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model Cell 149 2012 708 721
80. T. Watanabe, N. Yamagata, K. Takasaki, K. Sano, K. Hayakawa, S. Katsurabayashi, N. Egashira, K. Mishima, K. Iwasaki, and M. Fujiwara Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease Brain Res. 1249 2009 222 228
81. T.P. Wong, T. Debeir, K. Duff, and A.C. Cuello Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes J. Neurosci. 19 1999 2706 2716 (Pubitemid 29162418)
82. R.I. Westphalen, H.L. Scott, and P.R. Dodd Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease J. Neural Transm. 110 2003 1013 1027 (Pubitemid 37100405)
83. R.J. Wurtman Choline metabolism as a basis for the selective vulnerability of cholinergic neurons Trends Neurosci. 15 1992 117 122
84. W. Zhang, M. Bai, Y. Xi, J. Hao, L. Liu, N. Mao, C. Su, J. Miao, and Z. Li Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction Free Radic. Biol. Med. 52 2012 1443 1452